BCOR Mutations Deregulate Cell Cycle and Hypoxic Adaptation Pathways in Retinoblastoma.

Area of Science:

• Oncology
• Genetics
• Epigenetics

Background:

• Retinoblastoma (RB) is the most common pediatric eye cancer, often initiated by RB1 gene mutations.
• BCOR mutations occur in 20% of RB tumors, correlating with aggressive phenotypes and poor outcomes.
• The specific role of BCOR in RB pathogenesis remains largely uncharacterized.

Purpose of the Study:

• To investigate the function of BCOR in retinoblastoma.
• To elucidate the molecular mechanisms by which BCOR influences RB tumor progression.

Main Methods:

• Utilized low passage RB cell lines for analysis.
• Employed mass spectrometry, chromatin immunoprecipitation sequencing (ChIP-seq), and RNA sequencing.

Main Results:

• Identified BCOR protein interactions with the ncPRC1.1 Polycomb Repressive Complex.
• BCOR localizes to gene loci with both activating and repressing chromatin markers.
• BCOR loss downregulates cell cycle genes and upregulates hypoxic adaptation genes.

Conclusions:

• BCOR mutations in RB slow cell proliferation and induce hypoxic adaptation through epigenetic modifications.
• BCOR plays a multifaceted role in RB, impacting cell cycle, differentiation, and hypoxic adaptation.
• Understanding BCOR's molecular framework may lead to novel therapeutic strategies for retinoblastoma.